Skip to content

Evaluation of palatal mucosa anesthesia due to infiltration of lidocaine compared to articaine

Evaluation of palatal mucosa anesthesia due to infiltration of lidocaine compared to articaine in the buccal region of maxilla

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20131205015665N8
Enrollment
34
Registered
2025-09-05
Start date
2025-09-06
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparative evaluation of the effectiveness of articaine and lidocaine for achieving palatal anesthesia..

Interventions

Intervention 1: Intervention group: Participants are randomly assigned to receive articaine anesthesia on one side of the maxilla (left or right) which half a cartridge (equivalent to 0.9 mL) was inj

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: All people who are candidates for implants on both sides of the maxilla

Exclusion criteria

Exclusion criteria: Age less than 18 years History of trauma or nasal surgery History of psychiatric disorder Congenital anomalies Peripheral neuropathy or presence of sensory deficits in the facial area prior to surgery Uncontrolled systemic conditions

Design outcomes

Primary

MeasureTime frame
The amount of change in pain threshold. Timepoint: Before and 5 minutes after injection. Method of measurement: Light Touch (Semmes Weinstein monofilament) test.;The amount of change in sensory threshold. Timepoint: Before and 5 minutes after injection. Method of measurement: Light Touch (Semmes Weinstein monofilament) test.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Milad Etemadi

Esfahan University of Medical Sciences

etemadi@dnt.mui.ac.ir+98 31 3792 5521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026